FIGURE

Figure 7

ID

ZDB-FIG-210409-21

Publication

Haege et al., 2021 - Identification of Lactate as a Cardiac Protectant by Inhibiting Inflammation and Cardiac Hypertrophy Using a Zebrafish Acute Heart Failure Model

Other Figures

All Figure Page

Back to All Figure Page

Figure 7

Sodium lactate mechanisms. (A) COX-2 gene expression by qRT-PCR in zebrafish embryos treated with AA alone or with test chemicals: NS398, C25, sodium lactate, NS398; sodium lactate, or C25; sodium lactate. Sodium lactate suppresses COX-2 expression. (B) Relative levels of phosphorylated NF-κB in zebrafish embryos treated with different compounds. The quantification was done by measuring the pixels of the phosphorylated NF-κB bands and were normalized by that of β-actin on three Western blot images using Photoshop. Sodium lactate treated embryos showed a significantly lower level of phosphorylated NF-κB. (* indicates statistical significance by t-test, p = 0.001). (C) Additive effect of AHF attenuation by NS398 and sodium lactate. (Y axis: heart failure attenuation percentage). (D) Tnnt2 expression measured by qRT-PCR was significantly lower in the embryos treated with sodium lactate. (* indicates statistical significance by t-test, p < 0.05).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmaceuticals (Basel)